Khurshed Bozorov

Prof. Dr. Khurshed Bozorov

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
JZJiangyu Zhao
Jiangyu Zhao
Haji Akber AisaHaji Akber Aisa
Haji Akber Aisa

1 November 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
LNLi Fei Nie
Li Fei Nie
JZJiangyu Zhao
Jiangyu Zhao
Haji Akber AisaHaji Akber Aisa
Haji Akber Aisa

22 April 2020 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
Nigora RustamovaNigora Rustamova
Nigora Rustamova
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
Thomas EfferthThomas Efferth
Thomas Efferth
AYAbulimiti Yili
Abulimiti Yili

1 September 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
JZJiang-Yu Zhao
Jiang-Yu Zhao
BEBurkhon Elmuradov
Burkhon Elmuradov
APApar Pataer
Apar Pataer
Haji Akber AisaHaji Akber Aisa
Haji Akber Aisa

13 June 2017 in Molecules
Verified
Journal Article
Open access
PDF file
Sodik NumonovSodik Numonov
Sodik Numonov
SESalamet Edirs
Salamet Edirs
KBKhayrulla Bobakulov
Khayrulla Bobakulov
MQMuhammad Nasimullah Qureshi
Muhammad Nasimullah Qureshi
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
Haji Akber AisaHaji Akber Aisa
Haji Akber Aisa
The root of Geranium collinum Steph is known in Tajik traditional medicine for its hepatoprotective, antioxidant, and anti-inflammatory therapeutic effects. The present study was conducted to evaluate of potential antidiabetic, antioxidant activities, total polyphenolic and flavonoid content from the different extracts (aqueous, aqueous-ethanolic) and individual compounds isolated of the root parts of G. collinum. The 50% aqueous-ethanolic extract possesses potent antidiabetic activity, with IC50 values of 0.10 μg/mL and 0.09 μg/mL for the enzymes protein-tyrosine phosphatase (1B PTP-1B) and α-glucosidase, respectively. Phytochemical investigations of the 50% aqueous-ethanolic extract of G. collinum, led to the isolation of ten pure compounds identified as 3,3′,4,4′-tetra-O-methylellagic acid (1), 3,3′-di-O-methylellagic acid (2), quercetin (3), caffeic acid (4), (+)-catechin (5), (–)-epicatechin (6), (–)-epigallocatechin (7), gallic acid (8), β-sitosterol-3-O-β-d-glucopyranoside (9), and corilagin (10). Their structures were determined based on 1D and 2D NMR and mass spectrometric analyses. Three isolated compounds exhibited strong inhibitory activity against PTP-1B, with IC50 values below 0.9 μg/mL, more effective than the positive control (1.46 μg/mL). Molecular docking analysis suggests polyphenolic compounds such as corilagin, catechin and caffeic acid inhibit PTP-1B and β-sitosterol-3-O-β-d-gluco-pyranoside inhibits α-glucosidase. The experimental results suggest that the biological activity of G. collinum is related to its polyphenol contents. The results are also in agreement with computational investigations. Furthermore, the potent antidiabetic activity of the 50% aqueous-ethanolic extract from G. collinum shows promise for its future application in medicine. To the best of our knowledge, we hereby report, for the first time, the antidiabetic activity of G. collinum.

21 May 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ZMZarifa Murtazaeva
Zarifa Murtazaeva
ANAzizbek Nasrullaev
Azizbek Nasrullaev
ABAnvarjon Buronov
Anvarjon Buronov
SGShukhrat Gaybullaev
Shukhrat Gaybullaev
LNLifei Nie
Lifei Nie
Khurshed BozorovKhurshed Bozorov
Khurshed Bozorov
Imidazole is a five-membered heterocyclic system featuring two nitrogen heteroatoms at the 1- and 3-positions of the ring. The imidazole scaffold is particularly suited for kinase inhibition concepts. This further confirms that this scaffold is a privileged structure in the development of anticancer drugs. Considering these key factors and the recent focus of scientists on imidazole compounds, we discuss the anticancer activities of imidazole-containing hybrids and related compounds, highlighting articles published in 2023 that serve as a basis for medicinal chemistry leads. From a chemical perspective, the present review emphasizes hybrid molecules with an imidazole ring in the side chain, imidazole-centered hybrid molecules, condensed imidazole hybrids, hybrid compounds containing two or more imidazole rings, polycyclic imidazole hybrids, imidazole-containing metal complexes, and benzimidazole hybrids.